Active — Not RecruitingNot Applicable

A Study of Pulmonary Hypertension Peripheral Limitations

United States45 participantsStarted 2024-01-02

Plain-language summary

The investigators are doing this research study to compare whole body aerobic training with isolated leg training (with weights) and its impact on effectiveness in symptoms and quality of life in patients with Pulmonary Arterial Hypertension (PAH).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Pulmonary Arterial Hypertension (PAH) Subjects:
✓. Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial.
✓. NYHA Class II-IV
✓. LVEF ≥ 40 % within the preceding year.
✓. No hospitalizations due to heart failure in the preceding 30 days.
✓. No recent initiation of pulmonary vasodilator in the last 60 days
✓. Pulmonary arterial hypertension by right heart catheterization (Mean PA pressure ≥ 20 mmHg with PVR\>2 Wood units) with no evidence of heart failure with preserved ejection fraction (exercise PCWP \<25 mm Hg).
✓. Symptomatic PAH patients with plan to undergo exercise RHC for reassessment of exertional symptoms

What they're measuring

Change in skeletal muscle O2 diffusive conductance (Dm) during supine cycle exercise

Timeframe: Baseline, approximately 12 weeks

Trial details

NCT IDNCT05968859

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09

View on ClinicalTrials.gov More Pulmonary Arterial Hypertension trials